N-(4-methoxybenzyl)glucamine dithiocarbamate: reduces cadmium level in body; RN given refers to parent cpd; structure given in first source
ID Source | ID |
---|---|
PubMed CID | 119173 |
MeSH ID | M0167904 |
Synonym |
---|
meobgdtc |
(4-methoxyphenyl)methyl-[(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]carbamodithioic acid |
sodium n-(4-methoxybenzyl)-d-glucamine-n-carbodithioate monohydrate |
115384-16-2 |
d-glucitol, 1-deoxy-1-((dithiocarboxy)((4-methoxyphenyl)methyl)amino)- |
n-(4-methoxybenzyl)glucamine-n-carbodithioate |
n-(4-methoxybenzyl)glucamine dithiocarbamate |
115459-35-3 |
1-((dithiocarboxy)((4-methoxyphenyl)methyl)amino)-1-deoxy-d-glucitol |
n-(4-methoxybenzyl)-n-dithiocarboxy-d-glucamine |
1-deoxy-1-{[(4-methoxyphenyl)methyl](sulfanylcarbonothioyl)amino}hexitol |
DTXSID20921708 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (18.18) | 18.7374 |
1990's | 9 (81.82) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 15 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Article | Year |
---|---|
Schedule dependency of a cadmium-complexing dithiocarbamate analog in mice. Toxicology letters, Volume: 50, Issue: 1 | 1990 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |